<DOC>
	<DOCNO>NCT00351507</DOCNO>
	<brief_summary>This study design directly assess effect vildagliptin gastric empty people type 2 diabetes .</brief_summary>
	<brief_title>A Study Assess Effects Vildagliptin Gastric Emptying Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Diagnosed type 2 diabetes least 6 month Blood glucose criterion must meet BMI range 2240 History type 1 diabetes , diabetes result pancreatic injury , secondary form diabetes Use thiazolidinediones need insulin within 3 month prior screen Significant concomitant disease complication diabetes High fast triglyceride define protocol Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Vildagliptin</keyword>
	<keyword>Type 2 diabetes</keyword>
</DOC>